Works by Kim, Tae-You


Results: 144
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 707, doi. 10.1007/s00432-015-2072-5
    By:
    • Kim, Hyori;
    • Youk, Jeonghwan;
    • Yang, Yaewon;
    • Kim, Tae-Yong;
    • Min, Ahrum;
    • Ham, Hye-Seon;
    • Cho, Seongcheol;
    • Lee, Kyung-Hun;
    • Keam, Bhumsuk;
    • Han, Sae-Won;
    • Oh, Do-Youn;
    • Ryu, Han;
    • Han, Wonshik;
    • Park, In;
    • Kim, Tae-You;
    • Noh, Dong-Young;
    • Im, Seock-Ah
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer.

    Published in:
    Gastric Cancer, 2015, v. 18, n. 4, p. 824, doi. 10.1007/s10120-014-0420-9
    By:
    • Satoh, Taroh;
    • Lee, Kyung;
    • Rha, Sun;
    • Sasaki, Yasutsuna;
    • Park, Se;
    • Komatsu, Yoshito;
    • Yasui, Hirofumi;
    • Kim, Tae-You;
    • Yamaguchi, Kensei;
    • Fuse, Nozomu;
    • Yamada, Yasuhide;
    • Ura, Takashi;
    • Kim, Si-Young;
    • Munakata, Masaki;
    • Saitoh, Soh;
    • Nishio, Kazuto;
    • Morita, Satoshi;
    • Yamamoto, Eriko;
    • Zhang, Qingwei;
    • Kim, Jung-mi
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 109, doi. 10.1007/s00280-013-2174-1
    By:
    • Kim, Ji-Won;
    • Kim, Jee;
    • Im, Seock-Ah;
    • Kim, Yu;
    • Han, Hye-Suk;
    • Kim, Jin-Soo;
    • Lee, Kyung-Hun;
    • Kim, Tae-Yong;
    • Han, Sae-Won;
    • Jeon, Yoon;
    • Oh, Do-Youn;
    • Kim, Tae-You;
    • Park, In
    Publication type:
    Article
    38
    39

    Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 843, doi. 10.1007/s00280-013-2075-3
    By:
    • Lee, Kyung-Hun;
    • Chang, Hye;
    • Han, Sae-Won;
    • Oh, Do-Youn;
    • Im, Seock-Ah;
    • Bang, Yung-Jue;
    • Kim, Sun;
    • Lee, Keun-Wook;
    • Kim, Jee;
    • Hong, Yong;
    • Kim, Tae;
    • Park, Young;
    • Kang, Won;
    • Shin, Sang;
    • Ahn, Joong;
    • Kang, Gyeong;
    • Jeong, Seung-Yong;
    • Park, Kyu;
    • Park, Jae-Gahb;
    • Kim, Tae-You
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50